These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29330131)

  • 21. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes.
    Paci M; Hyttinen J; Aalto-Setälä K; Severi S
    Ann Biomed Eng; 2013 Nov; 41(11):2334-48. PubMed ID: 23722932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes.
    Hinata Y; Kagawa Y; Kubo H; Kato E; Baba A; Sasaki D; Matsuura K; Sawada K; Shimizu T
    J Pharmacol Toxicol Methods; 2022; 118():107228. PubMed ID: 36273536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the Direction and Order of the Motion Unveiled the Ability of Conventional Monolayers of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Show Frequency-Dependent Enhancement of Contraction and Relaxation Motion.
    Izumi-Nakaseko H; Chiba K; Hagiwara-Nagasawa M; Satsuka A; Goto A; Nunoi Y; Kambayashi R; Matsumoto A; Takei Y; Kanda Y; Naito AT; Sugiyama A
    Front Cell Dev Biol; 2020; 8():542562. PubMed ID: 33015053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
    Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets.
    Izumi-Nakaseko H; Kanda Y; Nakamura Y; Hagiwara-Nagasawa M; Wada T; Ando K; Naito AT; Sekino Y; Sugiyama A
    J Pharmacol Sci; 2017 Sep; 135(1):44-50. PubMed ID: 28928053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HiPSC-CMs from different sex and ethnic origin donors exhibit qualitatively different responses to several classes of pharmacological challenges.
    Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
    J Pharmacol Toxicol Methods; 2019; 99():106598. PubMed ID: 31201864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
    Zhang X; Guo L; Zeng H; White SL; Furniss M; Balasubramanian B; Lis E; Lagrutta A; Sannajust F; Zhao LL; Xi B; Wang X; Davis M; Abassi YA
    J Pharmacol Toxicol Methods; 2016; 81():201-16. PubMed ID: 27282640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
    Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker.
    Saito Y; Nakamura K; Yoshida M; Sugiyama H; Ohe T; Kurokawa J; Furukawa T; Takano M; Nagase S; Morita H; Kusano KF; Ito H
    PLoS One; 2015; 10(9):e0138193. PubMed ID: 26384234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
    Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
    Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biophysical, Molecular, and Pharmacological Characterization of Voltage-Dependent Sodium Channels From Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Moreau A; Mercier A; Thériault O; Boutjdir M; Burger B; Keller DI; Chahine M
    Can J Cardiol; 2017 Feb; 33(2):269-278. PubMed ID: 27998617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regionally diverse mitochondrial calcium signaling regulates spontaneous pacing in developing cardiomyocytes.
    Zhang XH; Wei H; Šarić T; Hescheler J; Cleemann L; Morad M
    Cell Calcium; 2015 May; 57(5-6):321-36. PubMed ID: 25746147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
    Qu Y; Vargas HM
    Toxicol Sci; 2015 Sep; 147(1):286-95. PubMed ID: 26117837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.